Axikin Pharmaceuticals
San Diego, US · Founded 2008 · Delaware corporation · 1 known investors
Find your way into Axikin Pharmaceuticals
Sign up to see every warm intro you have to Axikin Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Axikin Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
KB
Kevin B. BaconExecutive
PC

Peter C.M. McWilliamsExecutiveVenture Partner at Sanderling Ventures
Board
FA

Fred A. MiddletonBoard directorManaging Director at Sanderling Ventures
MM
Masaji MatsuokaBoard director
WO
Walter OlesiakBoard director
Investors · 1
Sanderling VenturesreportedSan Mateo · $50K – $1M
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$8.5M disclosed across 2 rounds · 2012–2014
▶$6.5MraisedSep 2015 · 7 investors · PharmaceuticalsRule 506(b)
▶$6.5MraisedSep 2015 · 7 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Fred A. MiddletonDirector
- Kevin B. BaconExecutive Officer, Director
- Peter C.M. McWilliamsExecutive Officer, Director
- Masaji MatsuokaDirector
- Offering amount
- $11.6M
- Amount sold
- $6.5M
- First sale
- Mar 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2MraisedMar 2012 · 2 investors · PharmaceuticalsRule 506(b)
▶$2MraisedMar 2012 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Fred A. MiddletonDirector
- Walter OlesiakDirector
- Peter C.M. McWilliamsExecutive Officer, Director
- Kevin B. BaconExecutive Officer, Director
- Offering amount
- $11M
- Amount sold
- $2M
- First sale
- Mar 2012
- Incorporated
- Corporation, Delaware, 2008
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Axikin Pharmaceuticals's investors?
- Axikin Pharmaceuticals's investors include Sanderling Ventures.
- How much funding has Axikin Pharmaceuticals raised?
- Axikin Pharmaceuticals has disclosed $8.5M raised across 2 rounds.
- Where is Axikin Pharmaceuticals headquartered?
- Axikin Pharmaceuticals is headquartered in San Diego, US.